{"url_path":"/sec/lmed/8-k/2026-08-11/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1477960/0001477932-26-004859-index.html","accession_number":"0001477932-26-004859","cik":"0001477960","ticker":"LMED","issuer_name":"LataMed AI Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1477960/0001477932-26-004859-index.html","primary_entity_key":"0001477960","primary_entity_name":"LataMed AI Corp."},"word_count":112,"has_tables":true,"body_markdown":"**Item 8.01 Other Events.**\n\n \n\nEffective August 11, 2026, LataMed AI Corp. (the “Company”) resumed trading under its permanent trading symbol **“LMED”** following the expiration of the temporary trading symbol **“LMEDD,”** which had been assigned in connection with the Company’s previously announced five-for-one (5-for-1) forward stock split.\n\n \n\nThe Company’s common stock will continue to trade on the OTC Markets under the symbol **LMED**.\n\n \n\n \n\n2\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n**LATAMED AI****CORP.**\n\n \n\n \n\n \n\n \n\nDated: August 11, 2026\n\nBy:\n\n*/s/ Kevin Rodan Levy*\n\n \n\n \n\n**Kevin Rodan Levy**\n\n \n\n \n\n \n\nChief Executive Officer\n\n \n\n \n\n \n\n3"}